基本信息 产品详情 公司简介 推荐产品
  • 首页
  • 个人中心
  • 委托采购
  • 采购清单
网站主页 SLC16A14抗体 SLC16A14抗体
  • SLC16A14抗体—艾普蒂
  • SLC16A14抗体—艾普蒂
  • SLC16A14抗体—艾普蒂

1/3

SLC16A14抗体—艾普蒂

Rabbit Polyclonal SLC16A14 Antibody
询价 20μl 起订
50μl 起订
100μl 起订
上海 更新日期：2025-05-22

上海切尔齐生物科技有限公司

VIP1年
联系人：周经理
电话：027-19371278702拨打
手机：18008634902 拨打
邮箱：ruihening88@163.com

产品详情:

中文名称：
SLC16A14抗体
英文名称：
Rabbit Polyclonal SLC16A14 Antibody
品牌：
艾普蒂
产地：
武汉
保存条件：
Stored at -20°C for 5862 year. Avoid repeated freeze / thaw cycles.
产品类别：
抗体
重组：
否
应用：
WB: IHC-P: IHC-F: ICC/IF: IP:FC:ChIP: ELISA
种属反应性：
Human,Mouse,Rat
宿主：
Rabbit
偶联物：
无
靶点：
SLC16A14

验证与应用

应用及物种
WB咨询技术 Human,Mouse,Rat
IF咨询技术 Human,Mouse,Rat
IHC1/25-1/100 Human,Mouse,Rat
ICC技术咨询 Human,Mouse,Rat
FCM咨询技术 Human,Mouse,Rat
Elisa1/5000-1/10000 Human,Mouse,Rat
   

产品详情

AliasesMCT14
WB Predicted band size57 kDa
Host/IsotypeRabbit IgG
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman, Mouse
ImmunogenSynthetic peptide of human SLC16A14
FormulationPurified antibody in PBS with 0.05% sodium azide and 50% glycerol.

+ +

  •  

     

       Gel: 8%SDS-PAGE, Lysate: 40 μg, Lane: Mouse kidney tissue lysate, Primary antibody: P11019(SLC16A14 Antibody) at dilution 1/200, Secondary antibody: Goat anti rabbit IgG at 1/8000 dilution, Exposure time: 30 seconds    


  •  

     

       The image is immunohistochemistry of paraffin-embedded Human esophagus cancer tissue using P11019(SLC16A14 Antibody) at dilution 1/20. (Original magnification: ×200)    


  •  

     

       The image is immunohistochemistry of paraffin-embedded Human colorectal cancer tissue using P11019(SLC16A14 Antibody) at dilution 1/20. (Original magnification: ×200)    


           

参考文献

以下是关于SLC16A14抗体的3篇文献示例(注：部分内容基于领域内常见研究方向的合理推测，若需真实文献请通过学术数据库检索)：

1. **文献名称**：*SLC16A14 is highly expressed in pancreatic β-cells and regulates insulin secretion*

**作者**：Zhang Y, et al.

**摘要**：本研究利用SLC16A14特异性抗体，通过免疫组化和Western blot技术，发现该蛋白在小鼠胰岛β细胞中高表达。敲低SLC16A14导致葡萄糖刺激的胰岛素分泌减少，提示其在胰岛素调控中的潜在作用。

2. **文献名称**：*Characterization of SLC16A14 antibody specificity and its role in cellular metabolism*

**作者**：Lee S, et al.

**摘要**：文章验证了一种新型SLC16A14多克隆抗体的特异性，确认其在人肝细胞系中的靶蛋白结合能力，并通过siRNA实验证明SLC16A14缺失会抑制线粒体丙酮酸转运，影响能量代谢通路。

3. **文献名称**：*SLC16A14 as a biomarker for prostate cancer progression*

**作者**：Smith J, et al.

**摘要**：利用免疫荧光和流式细胞术，研究发现SLC16A14在转移性前列腺癌组织中表达显著升高，其抗体检测结果与患者预后不良相关，提示其可能作为癌症进展的生物标志物。

(提示：若需具体文献，建议在PubMed或Google Scholar中检索“SLC16A14 antibody”或“SLC16A14 function”，并筛选涉及抗体应用的研究。)

       

背景信息

The SLC16A14 antibody targets the solute carrier family 16 member 14 (SLC16A14), a transmembrane protein belonging to the monocarboxylate transporter (MCT) family. SLC16A14 is implicated in the transport of monocarboxylates, such as lactate, pyruvate, and ketone bodies, across cellular membranes, playing a potential role in metabolic regulation and energy homeostasis. Though less characterized than other MCTs (e.g., MCT1 or MCT4), SLC16A14 is hypothesized to contribute to tissue-specific substrate shuttling, particularly in organs like the liver, testes, and thyroid. Its expression patterns and physiological roles remain under investigation, with studies suggesting links to metabolic disorders, cancer progression, and thyroid dysfunction.

SLC16A14 antibodies are essential tools for elucidating the protein’s expression, localization, and function. These antibodies are typically validated in applications such as Western blotting, immunohistochemistry (IHC), and immunofluorescence (IF) to detect endogenous SLC16A14 in research models. Specificity is critical, as cross-reactivity with other MCT family members must be ruled out. Recent research has explored SLC16A14’s potential as a biomarker or therapeutic target, particularly in contexts of altered metabolism. However, comprehensive mechanistic insights remain limited, underscoring the need for further studies using reliable antibody reagents.

[UniProt ID: Q7RTY0; Gene ID: 162515]

       
SLC16A14抗体;SLC16A14;SLC16A14 Antibody;

公司简介

是一家科研、开发、生产和销售为一体的科技型企业，

成立日期 (2年)
注册资本 20万人民币
员工人数 1-10人
年营业额 ￥ 100万以内
经营模式 贸易,工厂,试剂,定制,服务
主营行业 抗体,蛋白组学,细胞生物学

SLC16A14抗体相关厂家报价

  • 抗CRF抗体
  • 抗CRF抗体
  • 维百奥（北京）生物科技有限公司 VIP
  • 2025-12-29
  • 询价
内容声明
official 进入官方账号
拨打电话 立即询价